Anthem Biosciences raised ₹1,016.02 crore from 60 institutional investors ahead of its IPO launch on July 14. The offering, entirely an offer-for-sale worth ₹3,395 crore, is priced between ₹540 and ₹570 per share, with a market cap of ₹31,800 crore.
Anthem Biosciences raised ₹1,016.02 crore from 60 institutional investors ahead of its IPO launch on July 14. The offering, entirely an offer-for-sale worth ₹3,395 crore, is priced between ₹540 and ₹570 per share, with a market cap of ₹31,800 crore.